Lu Dai

I was born in December 1989 in Shaoxing, a city in southeastern China renowned for historical and cultural relics in China. I moved to the north (Tianjin) for 5-years medical studies at Tianjin University of Traditional Chinese Medicine (TUTCM) where I got my M.D. degree in 2013, followed by a Master of Medicine degree after studies on thrombin mediated PAR-1/NF-κB transduction in renal fibrosis, and then one-year clinical training in nephrology. In 2016, I received a China Scholarship Council fellowship for clinical research studies at Renal Medicine, Karolinska Institutet where I learned clinical research methodology, data handling skills and writing of manuscripts. This motivated me to apply for a PhD position in the INTRICARE program, as this would allow me to strengthen and use my abovementioned skills into the study of underlying mechanisms of microcalcification, vascular remodeling and vulnerable plaque formation. My major research focus will be to explore the hypothesis that uremic microcalcification is not only caused by phosphate retention, but also by persistent inflammation, vitamin K deficiency, inactive MGP, and increased vascular expression of apoptotic genes and bone proteins. With my clinical background, I will have a better understanding of translational medicine as a means to discover new preventive and therapeutic solutions to premature ageing in chronic kidney disease patients. I am happy to be part of this wonderful networking program, and looking forward to working with nice people.

Back to overview